Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001641172-25-016163
Filing Date
2025-06-24
Accepted
2025-06-23 18:23:23
Documents
12

Document Format Files

Seq Description Document Type Size
1 S-1/A forms-1a.htm S-1/A 722877
2 EX-1.1 ex1-1.htm EX-1.1 224034
3 EX-5.1 ex5-1.htm EX-5.1 18215
4 EX-23.1 ex23-1.htm EX-23.1 3796
5 GRAPHIC ex5-1_001.jpg GRAPHIC 16772
6 GRAPHIC ex5-1_002.jpg GRAPHIC 4679
7 GRAPHIC forms-1_001.jpg GRAPHIC 71086
8 GRAPHIC forms-1_002.jpg GRAPHIC 19299
9 GRAPHIC forms-1_003.jpg GRAPHIC 21135
10 GRAPHIC forms-1_004.jpg GRAPHIC 17913
11 GRAPHIC ex1-1_001.jpg GRAPHIC 14481
12 GRAPHIC ex1-1_002.jpg GRAPHIC 41807
  Complete submission text file 0001641172-25-016163.txt   1256470
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

EIN.: 202903526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-288120 | Film No.: 251066190
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)